Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Federal Trade Commission
Healthtrust
McKinsey
AstraZeneca

Generated: July 17, 2019

DrugPatentWatch Database Preview

Litigation Details for ACORDA THERAPEUTICS, INC. v. APOTEX INC. (D.N.J. 2007)

Try a free trialSee Plans and Pricing

« Back to Dashboard

ACORDA THERAPEUTICS, INC. v. APOTEX INC. (D.N.J. 2007)

Docket ➤ Sign Up Date Filed 2007-10-11
Court District Court, D. New Jersey Date Terminated 2011-09-06
Cause 35:271 Patent Infringement Assigned To Garrett E. Brown Jr.
Jury Demand None Referred To Madeline Cox Arleo
Parties ACORDA THERAPEUTICS, INC.; APOTEX CORP.; APOTEX INC.
Patents 6,455,557
Attorneys BRIAN J. MCMAHON; GEOFFREY A. NORTH; JOSEPH NICHOLAS FROEHLICH; KEVIN J. MCKENNA; WILLIAM P. DENI , JR.
Firms Greenberg Traurig LLP
Link to Docket External link to docket
Small Molecule Drugs cited in ACORDA THERAPEUTICS, INC. v. APOTEX INC.
The small molecule drug covered by the patent cited in this case is ➤ Sign Up .

Details for ACORDA THERAPEUTICS, INC. v. APOTEX INC. (D.N.J. 2007)

Date Filed Document No. Description Snippet Link To Document
2011-09-06 281 Apotex infringes U.S. Patent No. 6,455,557 (“the ‘557 patent”). The patent is directed generally to… to reduce somnolence. (U.S. Patent No. 6,455,557 (“the ‘557 patent”) at 14:8-34). However, the … Finds that the Patent Claims Involve Patentable Subject Matter The Patent Act provides “[w…557 patent claims patentable subject matter. Apotex proceeds on the premise that the patented methods…49 A. The Court Finds that the Patent Claims Involve Patentable Subject 49 External link to document
2008-12-29 41 alleging infringement of its patent, U.S. Patent No. 6,455,557 (“the ’557 patent”). Specifically, in its … “has infringed at least one claim of the ’557 patent by submitting, or causing to be submitted to the…capsules before the expiration date of the ‘557 patent.” (Compl. ¶ 15.) As part of its prayer for relief…attorneys fees under Section 285.” In typical patent infringement cases, the United States Court of … 6 September 2011 2:07-cv-04937 830 Patent None District Court, D. New Jersey External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Argus Health
Boehringer Ingelheim
QuintilesIMS
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.